AGI-24512 is a novel, potent and seletive MATA2 (methionine adenosyltransferase 2A) inhibitor with potential anticancer activities by blocking the growth of MTAP-deleted cancer cells in vitro. AGI-24512 also showed in vivo antitumor activity in MTAP null tumors.